Here we report that two Notch targets, SYGL-1 and LST-1, link niche signaling to FBF
The proportion of patients using basal insulin, which initially was higher in the CKD group, did not change greatly after 12 months, although the dose of basal insulin was reduced, albeit non-significantly: 36.0 (22.050.0) IU/mL vs
10.1016/s0168-8227(88)80022-6 122 WculekS
Semaglutide, originally developed to help manage blood sugar and aid in weight loss, has gained attention for its potential benefits beyond diabetes care
Propionyl-L-Carnitine: Focused on cardiovascular health
The authors propose that 3-month response status whether the patient achieves 5% body weight reduction may function as a clinical decision point, with patients who fail to reach this threshold showing limited additional benefit from GLP-1 monotherapy continuation in their cohort